Total Company Value: Evolus, Inc. (EOLS)

Evolus Corp - graphic logo of issuer EOLS

Evolus, Inc. (EOLS) is expanding its aesthetic medicine business, focusing on European expansion and attracting younger clients through Jeuveau. However, intense competition and pressure from low-cost Asian alternatives are forcing the company to fight for clinic loyalty. Simultaneously, the company is implementing software for patient tracking and predictive analytics. This market valuation chart confirms these trends, with the current figure standing at 606.42.

EOLS evolus.com Real Price to Acquire Entire Company (11/23/2025 - 10/28/2026)

Financial and market metric breakdowns for Evolus, Inc. (EOLS)

- price and consensus price forecast:
Market Price Evolus Inc|EOLS - Price Target Chart
- market capitalization data:
Market Value Evolus|EOLS - Total Company Value
- book capitalization data:
Net Assets per Share Evolus|EOLS - Company Net Assets|Market Cap to Book Value Multiple evolus.com|EOLS - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Evolus, Inc.|EOLS - Long-Term Debt to Capital|Current Liabilities to Capital evolus.com|EOLS - Company Aggregate Debts|Debts to Book Capitalization Evolus|EOLS - Company Long-Term Liabilities|Amount of Current Liabilities Evolus
Summary company analytics:EOLS - Evolus Inc
Original product of Jeuveau

When screening assets, an investor uses this metric to determine the actual cost of acquiring a business by summing the market capitalization and net debt. The calculation logic of Enterprise Value (EV) allows for an assessment of the financial stability of Evolus, Inc. (EOLS) amid price wars with Asian competitors in the aesthetic medicine segment, revealing the real price of the asset inclusive of all credit obligations.

Competitors of Evolus, Inc.

HCA Inc. - Total Enterprise Value|THC - Total Company Value|FMS: Total Company Value|Solventum Corporation - Total Company Value|Company Buyout Price encompasshealth.com|Universal Health Services Inc (UHS) - Real Price to Acquire Entire Company|Aggregate Business Value DVA|RadNet Corp (RDNT) - Total Company Value|Value Adjusted for Debt and Cash Option Care Corp (OPCH)|SGRY: Enterprise Value|Total Enterprise Value premierinc.com PINC|National Vision - Enterprise Value|Progyny Inc (PGNY) - Enterprise Value|ARDT - Real Price to Acquire Entire Company|SEM (Select Medical Inc.) - Aggregate Business Value|Total Company Value ASTH|Real Price to Acquire Entire Company MEDNAX|U.S. Physical Therapy - Enterprise Value|Total Enterprise Value PNTG (Pennant Group)|ORGO - Total Company Value|NUTX - Business Value|Real Price to Acquire Entire Company Auna SA AUNA|SBC - Aggregate Business Value|Enterprise Value CYH|Total Enterprise Value BeautyHealth|Real Price to Acquire Entire Company MediWound Ltd|Total Company Value BTMD|The Joint Corp. - Total Company Value|Total Enterprise Value DCGO (docgo.com)|Total Company Value P3 Health Partners PIII|GANX - Total Company Value|EUDA Health Holdings Limited - Real Price to Acquire Entire Company|BMGL: Enterprise Value|collplant.com - Total Company Value|Company Buyout Price cuprina.com.sg|CCM - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash American Shared Hospital Services Inc|MRM (MEDIROM Healthcare Group Inc) - Enterprise Value|Company Buyout Price ALBT (avalon-globocare.com)|DHAI - Total Company Value|Business Value carmellcosmetics.com XAGE|NIVF: Enterprise Value|ATI Physical Therapy (ATIP) - Real Price to Acquire Entire Company|CareMax Medical Group - Real Price to Acquire Entire Company|Kindly Health (KDLY) - Company Buyout Price|Enterprise Value MODV (ModivCare Inc.)|Total Enterprise Value NVOS|SunLink Health Systems - Total Company Value|Total Enterprise Value BACK (IMAC Holdings Inc)